Targeted cancer therapy (HER2-directed monoclonal antibodies)
Last reviewed April 2026
Who is this for?
Pertuzumab and Trastuzumab (sold as Phesgo in Nigeria) is a combination of two cancer-fighting medicines that work together by targeting a specific protein called HER2 on the surface of certain breast cancer cells, blocking the signals that tell cancer cells to grow and multiply.
Prescription Required
You need a doctor's prescription to buy this drug.
Explore this drug